Literature DB >> 19875471

Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements.

S Bisdas1, Z Rumboldt, K Surlan-Popovic, M Baghi, T S Koh, T J Vogl, M G Mack.   

Abstract

BACKGROUND AND
PURPOSE: PCT studies hold short-term predictive value in patients treated with chemoradiotherapy. Our aim was to examine the long-term predictive value of baseline PCT studies for local tumor control and overall survival in SCCA of the upper aerodigestive tract treated with chemoradiotherapy.
MATERIALS AND METHODS: Eighty-four patients with advanced SCCA underwent PCT followed by concomitant chemoradiation. The acquired perfusion maps represented BF, BV, MTT, and PS. Visual analysis of the parametric maps for identification of tumor perfusion patterns was conducted. ROC curves, t tests, and Kaplan-Meier survival curves were plotted for local disease control and overall survival.
RESULTS: The median time of local tumor control was 24 months. The BF and PS values were significantly higher in patients who had no recurrence than in those with local failure (P < or = .02). The BF and PS were predictive (P < or = .0006) but BV and MTT held no significant predictive values for local tumor control. The patients with high BF and PS had a longer local tumor control than the patients with hypoperfused tumors (P = .0007). A visually detected BF-BV mismatch had a sensitivity/specificity of 63%/66% (P = .03) and 59%/69% (P = .03) for local tumor control and OS, respectively. Patients without mismatch lived significantly longer than patients with mismatch (P = .01).
CONCLUSIONS: BF, PS, and mismatch of BF-BV are significant predictors of local tumor control after chemoradiation in SCCA of the upper aerodigestive tract.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875471      PMCID: PMC7963990          DOI: 10.3174/ajnr.A1852

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  31 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

Review 2.  Oxygen transport in tumors: characteristics and clinical implications.

Authors:  P Vaupel
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

3.  An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: II. Experimental validation.

Authors:  K S St Lawrence; T Y Lee
Journal:  J Cereb Blood Flow Metab       Date:  1998-12       Impact factor: 6.200

Review 4.  Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.

Authors:  Håkan Axelson; Erik Fredlund; Marie Ovenberger; Göran Landberg; Sven Påhlman
Journal:  Semin Cell Dev Biol       Date:  2005-04-26       Impact factor: 7.727

5.  Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?

Authors:  A Zima; R Carlos; D Gandhi; I Case; T Teknos; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

6.  High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.

Authors:  Ezra E W Cohen; Daniel J Haraf; Marcy A List; Masha Kocherginsky; Bharat B Mittal; Fred Rosen; Bruce Brockstein; Rosalyn Williams; Mary Ellyn Witt; Kerstin M Stenson; Merrill S Kies; Everett E Vokes
Journal:  J Clin Oncol       Date:  2006-07-20       Impact factor: 44.544

7.  Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer.

Authors:  Nina A Mayr; Jian Z Wang; Dongqing Zhang; Joseph F Montebello; John C Grecula; Simon S Lo; Jeffery M Fowler; William T C Yuh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-13       Impact factor: 7.038

8.  Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies.

Authors:  Sotirios Bisdas; Mehran Baghi; Agnieszka Smolarz; Nicole Chambron Pihno; Thomas Lehnert; Rainald Knecht; Martin G Mack; Thomas J Vogl; Sehib Tuerkay; Tong San Koh
Journal:  Invest Radiol       Date:  2007-03       Impact factor: 6.016

9.  A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract.

Authors:  Sotirios Bisdas; Leon Medov; Mehran Baghi; George N Konstantinou; Jens Wagenblast; Choon Hua Thng; Thomas J Vogl; Tong San Koh
Journal:  Eur Radiol       Date:  2008-01-04       Impact factor: 5.315

10.  Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy.

Authors:  Paola A G Pedruzzi; Luiz P Kowalski; Ines N Nishimoto; Benedito V Oliveira; Fabio Tironi; Gyl H A Ramos
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-11
View more
  17 in total

Review 1.  Biologic imaging of head and neck cancer: the present and the future.

Authors:  A Srinivasan; S Mohan; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

2.  Combined PET/CT-perfusion in patients with head and neck cancers.

Authors:  Patrick Veit-Haibach; Daniel Schmid; Klaus Strobel; Jan D Soyka; Niklaus G Schaefer; Stephan K Haerle; Gerhard Huber; Gabriele Studer; Burkhardt Seifert; Thomas F Hany
Journal:  Eur Radiol       Date:  2012-07-08       Impact factor: 5.315

3.  Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy.

Authors:  M T Truong; N Saito; A Ozonoff; J Wang; R Lee; M M Qureshi; S Jalisi; O Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

4.  CT perfusion of head and neck cancer: why we should care versus why should we care!

Authors:  S K Mukherji; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-19       Impact factor: 3.825

5.  Correlating computed tomography perfusion changes in the pharyngeal constrictor muscles during head-and-neck radiotherapy to dysphagia outcome.

Authors:  Minh Tam Truong; Richard Lee; Naoko Saito; Muhammad M Qureshi; Al Ozonoff; Paul B Romesser; Jimmy Wang; Osamu Sakai
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-12       Impact factor: 7.038

6.  Predicting response to neoadjuvant chemotherapy in primary breast cancer using volumetric helical perfusion computed tomography: a preliminary study.

Authors:  Sonia P Li; Andreas Makris; Andrew Gogbashian; Ian C Simcock; J James Stirling; Vicky Goh
Journal:  Eur Radiol       Date:  2012-04-17       Impact factor: 5.315

7.  Radiochemotherapy-induced changes of tumour vascularity and blood supply estimated by dynamic contrast-enhanced CT and fractal analysis in malignant head and neck tumours.

Authors:  A Abramyuk; V Hietschold; S Appold; R von Kummer; N Abolmaali
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

8.  Head and neck tumors: assessment of perfusion-related parameters and diffusion coefficients based on the intravoxel incoherent motion model.

Authors:  M Sumi; T Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-02       Impact factor: 3.825

9.  Intravoxel Incoherent Motion-Magnetic Resonance Imaging as an Early Predictor of Treatment Response to Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.

Authors:  Youping Xiao; Jianji Pan; Yunbin Chen; Ying Chen; Zhuangzhen He; Xiang Zheng
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

10.  Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography.

Authors:  K A Miles; T-Y Lee; V Goh; E Klotz; C Cuenod; S Bisdas; A M Groves; M P Hayball; R Alonzi; T Brunner
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.